Literature DB >> 21617124

Trials and tribulations of new agents, novel biomarkers, and retarding renal progression.

Adeera Levin, Monica C Beaulieu.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21617124     DOI: 10.1681/ASN.2011040402

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  2 in total

1.  Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways.

Authors:  Xuan Xiong; Wenjuan Mei; Yanyun Xie; Jishi Liu; Miaomiao Lu; Xiongqun Peng; Congyin Yang; Xin Zhang; Mingyan Xie; Renna Luo; Xiangning Yuan; Ling Huang; Lin Wu; Jiao Qin; Yu Peng; Xiujie Jia; Gaoyun Hu; Damu Tang; Lijian Tao
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 2.  Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition-An Outstanding Challenge.

Authors:  Attila Fintha; Ákos Gasparics; László Rosivall; Attila Sebe
Journal:  Front Pharmacol       Date:  2019-04-18       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.